News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,200 Results
Type
Article (26400)
Company Profile (60)
Press Release (367738)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104482)
Career Advice (455)
Deals (16906)
Drug Delivery (53)
Drug Development (47759)
Employer Resources (47)
FDA (12352)
Job Trends (8492)
News (186526)
Policy (19571)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1760)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26851)
ALS (95)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12686)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6900)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3059)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (28)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (42959)
Collaboration (849)
Compensation (271)
Complete response letters (16)
COVID-19 (1553)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4222)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3714)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38633)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54218)
Executive appointments (584)
FDA (14627)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (750)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (541)
Government (3150)
Grass and pollen (4)
Guidances (229)
Healthcare (12212)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (67)
Infectious disease (1685)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (52)
Intellectual property (118)
Interviews (40)
IPO (7077)
IRA (23)
Job creations (1847)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (195)
Leadership (8)
Legal (3654)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (288)
MASH (105)
Medical device (13300)
Medtech (13345)
Mergers & acquisitions (10342)
Metabolic disorders (750)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1687)
NextGen: Class of 2026 (3937)
Non-profit (2838)
Now hiring (33)
Obesity (310)
Opinion (96)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (349)
Peanut (42)
People (35683)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12340)
Phase 2 (18576)
Phase 3 (15277)
Pipeline (3023)
Policy (125)
Postmarket research (1669)
Preclinical (3799)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (425)
Real estate (2874)
Recruiting (18)
Regulatory (15716)
Reports (18)
Research institute (1653)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (106)
Sponsored (16)
Startups (2137)
Stomach cancer (11)
Supply chain (60)
Tariffs (26)
The Weekly (14)
Vaccines (504)
Venture capital (27)
Weight loss (209)
Women's health (54)
Worklife (4)
Date
Last 7 days (303)
Last 30 days (1038)
Last 365 days (16132)
2026 (1472)
2025 (16478)
2024 (19852)
2023 (22741)
2022 (30692)
2021 (33002)
2020 (32215)
2019 (28451)
2018 (21856)
2017 (18955)
2016 (18152)
2015 (21231)
2014 (16048)
2013 (13253)
2012 (14361)
2011 (14635)
2010 (13189)
Location
Africa (369)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25499)
Australia (4031)
California (5570)
Canada (1904)
China (782)
Colorado (285)
Connecticut (285)
Delaware (249)
Europe (49896)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (577)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3737)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1922)
New Mexico (15)
New York (1562)
North Carolina (810)
North Dakota (4)
Northern California (2644)
Ohio (213)
Oklahoma (8)
Oregon (28)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (35)
South America (525)
South Carolina (59)
Southern California (2236)
Tennessee (124)
Texas (1017)
United States (21606)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,200 Results for "mercury medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein Cargo to the Brain
October 1, 2025
·
1 min read
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Press Releases
Frame Bio Licenses Novel Drug Delivery Technology from Mercury Bio to Develop Regenerative Therapies for Bone and Collagen Diseases and Disorders
September 18, 2025
·
1 min read
Business
Mercury Bio Joins the Alliance for mRNA Medicines
Mercury Bio today announced that it has joined the Alliance for mRNA Medicines as a charter member, and that Chief Science Officer Richard Sayre, Ph.D. has joined the Alliance for mRNA Medicines (AMM) board.
January 23, 2024
·
2 min read
Mercury Bio Strengthens Board of Directors with Appointment of Life Science Tools Veteran Mike Rice
Mercury Bio, (www.mercurybio.com) a Santa Fe, NM-based biotech company commercializing an innovative and highly disruptive drug delivery platform
November 21, 2023
·
1 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Mercury Bio Executives to Present Novel, Disruptive Drug Delivery Platform at 2024 Biotech Showcase
Mercury Bio, (www.mercurybio.com) a Santa Fe, NM–based biotech company commercializing an innovative and highly disruptive drug delivery platform, today announced that Chief Executive Officer Bruce McCormick and Chief Science Officer Richard Sayre, Ph.D., will be presenting at the 2024 Biotech Showcase investors and corporate development conference at 11:00 AM on Monday, January 8, 2024.
December 20, 2023
·
2 min read
BioMidwest
Mercury Medical Receives EU Quality Management Medical Device (MDR) Certification
Mercury Medical recently received MDR CE Mark Certification for their CPR manual resuscitation line.
July 27, 2022
·
2 min read
Business
Mercury Bio and Himed Enter R&D Agreement to Develop Novel Osteogenic Material for Orthopedic Applications
Mercury Bio has entered into a joint research, development, and licensing agreement with Old Bethpage, NY -based Himed.
July 13, 2023
·
3 min read
FDA
Medovate Announces Exclusive US Distribution Agreement with Mercury Medical(R) for SAFIRA(R)
Medovate has announced that it has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA.
February 9, 2022
·
4 min read
1 of 39,420
Next
